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Local degradation of connective tissue in the vicinity of the cell
surface is thought to play an essential role for tumour cell invasion
and metastasis. Degradation of extracellular matrix components is
accomplished through an array of proteolytic enzymes including
members of both the matrix metalloproteinase (MMP) and serine
protease families (Birkedal-Hansen et al, 1993; Stetler-Stevenson
et al, 1993; Yu et al, 1997).
Among MMPs, the type IV collagenases MMP-2 and MMP-9
are considered to play a critical role in tumour progression.
Elevated expression and activation of MMP-2 and MMP-9 have
been strongly correlated with the invasive phenotype of tumours
like squamous cell carcinomas (Pyke et al, 1992; Kusukawa et al,
1993), gastric (Brown et al, 1990), and breast (Okada et al, 1995)
carcinomas.
Like most MMPs, MMP-2 (gelatinase A, 72-kDa type IV colla-
genase) is secreted as an inactive zymogen that has to be activated
by removal of the N-terminal propeptide. In vitro, serine proteases
have been shown to activate most MMPs (Birkedal-Hansen et al,
1993). However, MMP-2 is unique among the MMPs in that its
activation is achieved in a membrane-associated manner by
membrane-type matrix metalloproteinases (MT-MMPs), such as
MT1-MMP (Sato et al, 1994). MT1-MMP (MMP-14) is also
synthesized as a proform which can be activated both intracellu-
larly by the serine protease furin (Pei and Weiss, 1996), and extra-
cellularly by plasmin (Okumura et al, 1997) and urokinase-type
plasminogen activator (Kazes et al, 1998). Although five different
membrane-bound MMPs have been described thus far (Sato et al,
1994; Takino et al, 1995; Will and Hinzmann, 1995; Puente et al,
1996; Butler et al, 1997; Pei, 1999), among them MT2-, MT3-,
and MT5-MMP have been reported to activate proMMP-2, MT1-
MMP is the one with the best documented correlation to the inva-
sive phenotype of different types of cancer (Okada et al, 1995;
Tsunezuka et al, 1996; Gilles et al, 1997; Nakamura et al, 1999).
MT1-MMP production or activation has been shown in vitro to be
up-regulated by fibrillar type I collagen (Azzam and Thompson,
1992; Seltzer et al, 1994; Haas et al, 1998; Kurschat et al, 1999),
an interaction which is likely to occur in vivo when tumour cells
invade the surrounding stroma. The activation of proMMP-2 by
MT1-MMP has been reported to be dependent on the presence of
low amounts of the tissue inhibitor of matrix metalloproteinases
(TIMP)-2, which is required as a bridging molecule for the forma-
tion of a membrane-bound activation complex composed of MT1-
MMP, TIMP-2 and latent MMP-2 (Strongin et al, 1995; Butler
et al, 1998). At high concentrations, however, TIMP-2 has been
shown to inhibit proMMP-2 activation, presumably by blocking
the activity of MT1-MMP (Will et al, 1996; Itoh et al, 1998;
Zucker et al, 1998).
The spontaneously immortalized non-tumorigenic human
keratinocyte cell line HaCaT (Boukamp et al, 1988) and the
c-rasHa transfected HaCaT clones (Boukamp et al, 1990) provide
an excellent model to study cellular changes associated with
malignant progression of epithelial cells. While HaCaT cells
reveal a nearly normal epidermal phenotype upon transplantation
onto athymic nude mice (Breitkreutz et al, 1998), the malignant
variants of the c-ras clones grow invasively and form squamous
Membrane-type 1 matrix metalloproteinase-mediated
progelatinase A activation in non-tumorigenic and
tumorigenic human keratinocytes
P Baumann1, P Zigrino1, C Mauch1, D Breitkreutz2 and R Nischt1
1Department of Dermatology, University of Cologne, 50924 Köln; 2German Cancer Research Center, Division of Carcinogenesis and Differentiation,
69120 Heidelberg, Germany
Summary Elevated expression of type IV collagenases (MMP-2 and MMP-9) has been strongly correlated with tumour progression and
metastasis in various tumours. Here, we analysed expression and activation of these MMPs in non-tumourigenic HaCaT cells and the
malignant HaCaT variant II-4rt. In monolayer cultures, both cell types secreted latent MMP-2 (proMMP-2) in comparable amounts, while MMP-
9 production was clearly higher in II-4rt cells. Upon contact with fibrillar collagen type I the malignant II-4rt cells, but not the HaCaT cells, gained
the capability to activate proMMP-2. This process is shown to be membrane-associated and mediated by MT1-MMP. Surprisingly, all
membrane preparations from either HaCaT cells or II-4rt cells grown as monolayers, as well as within collagen gels, contained considerable
amounts of active MT1-MMP. However, within collagen gels HaCaT cells showed significantly higher TIMP-2 levels compared to II-4rt cells.
This indicates that TIMP-2 might play a central role for MT1-MMP-mediated gelatinolytic activity. Indeed, collagen type I-induced MT1-MMP-
mediated proMMP-2 activation by II-4rt membranes could be completely abolished by an excess of TIMP-2. In conclusion, our data suggest
that MT1-MMP-mediated proMMP-2 activation might be associated with malignant progression of epidermal tumour cells. © 2000 Cancer
Research Campaign
Keywords: type IV collagenases; activation; keratinocytes; HaCaT-ras; cell–matrix interactions
1387
Received 11 May 2000
Revised 12 July 2000
Accepted 18 July 2000
Correspondence to: R Nischt
British Journal of Cancer (2000) 83(10), 1387–1393
© 2000 Cancer Research Campaign
doi: 10.1054/ bjoc.2000.1454, available online at http://www.idealibrary.com on 1388 P Baumann et al
British Journal of Cancer (2000) 83(10), 1387–1393 © 2000 Cancer Research Campaign
cell carcinoma-like tumours showing severe alterations at the
cell-matrix interface (Tomakidi et al, 1999). In the present study,
we analysed MMP-2 and MMP-9 expression in HaCaT cells and
the c-rasHa transfected HaCaT clone II-4rt to determine whether
alterations in the production of these MMPs are associated with
acquisition of the malignant phenotype.
MATERIALS AND METHODS
Cells and and culture conditions
HaCaT cells, a non-tumorigenic keratinocyte cell line and the c-
rasHa transfected tumourigenic HaCaT cell clone II-4rt were kindly
provided by Dr N Fusenig (German Cancer Research Center,
Heidelberg, Germany). Both cell lines were routinely cultured in
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% fetal calf serum (FCS), 2 mM glutamine and 100 U ml–1 each
of penicillin and streptomycin. Three-dimensional collagen type I
lattices were prepared as described previously (Mauch et al, 1988).
Briefly, 4 ´ 105 cells ml–1 were seeded into collagen gels
containing 2.4 mg ml–1 bovine collagen type I (Cellon, Cell
Systems, Germany).
Preparation of conditioned media
Cells were cultured as monolayers on collagen type I-coated
dishes (10 mg cm–2) or within collagen gels with daily medium
changes. At indicated time-points the cultures were washed with
phosphate buffered saline (PBS) and the medium replaced by
serum-free DMEM. 24 h later the media were collected, the cells
trypsinized, or released from the collagen gels by treatment with
bacterial collagenase D (1 mg ml–1) and counted. Alternatively,
conditioned media and cells grown as monolayers or in collagen
gels were combined and homogenized by sonication. For inhibi-
tion experiments the cell suspensions were preincubated for 30
min with the synthetic furin inhibitor Decanoyl-Arg-Val-Lys-Arg-
chloromethylketone (CMK; Bachem Biochemicals, Germany),
with the CMK solvent methanol, with aprotinin (ROTH,
Germany), or with 1,10 phenanthroline (Sigma, Germany) and
then seeded into collagen gels. The inhibitors were added at the
following concentrations: CMK = 25 and 50 mM; aprotinin =
10 mM; 1,10 phenanthroline = 10 and 20 mM. The peptides UKI
and ni68 (20 mg ml–1) inhibiting uPA and interaction of uPA with
its receptor, respectively, were also included. Both inhibitors were
kindly provided by Dr V Magdolen (Department of Gynaecology,
Technical University, Klinikum rechts der Isar, Munich,
Germany). After 24 h the cultures were washed with PBS and
further cultivated for 24 h in serum-free DMEM containing the
inhibitor. Then the culture samples were processed as described
before.
Gelatin zymography
For gelatin zymography supernatants corresponding to 1.5 ´ 104
cells or 10 ml homogenates of combined media and cells were sepa-
rated on non-reducing 10% SDS polyacrylamide gels containing 1
mg ml–1 bovine gelatin (Sigma, Germany) (Herron et al, 1986).
After electrophoresis the gels were washed in 2.5% Triton X-100
for 30 min and then incubated in enzyme substrate buffer (50 mM
Tris-HCl, pH 8.5, 5 mM CaCl2) overnight at 37°C. Gels were
stained with Coomassie Blue R250 and destained in water.
Preparation of crude membranes
For preparation of crude plasma membranes the collagen gels
were disrupted by mechanical shearing through a 10 ml syringe
and subsequent incubation with bacterial collagenase D
(1 mg ml–1) for approximately 10 min until no visible collagen
fibres were left. After addition of half a volume of FCS the cells
were pelleted (2000 g for 5 min at 4°C) and resuspended in PBS
containing 1 mM Pefabloc (Boehringer Mannheim, Germany),
10 mg ml–1 aprotinin and 1 mg ml–1 leupeptin (Sigma, Germany).
After cell lysis by three cycles of freezing in liquid nitrogen and
thawing, the lysate was homogenized by sonification. The plasma
membranes were pelleted by centrifugation (150 000 g for 30 min
at 4°C) and resuspended in PBS. The protein concentration was
determined using a commercial assay (Bio-Rad, Germany). For
activity assays 10 mg of the membrane preparations were incu-
bated overnight at 37°C with 20 ml fibroblast-conditioned medium
containing proMMP-2. Incubations were performed in the pres-
ence of 1, 5 or 10 mg of anti-MT1-MMP peptide antibodies
blocking specifically MT1-MMP-mediated proMMP-2 activation
(raised against a peptide corresponding to the residues 160–173 of
human MT1-MMP, clone 114–1F2, Fuji Chemicals, Japan) or in
the presence of 3.8 or 7.6 nM recombinant TIMP-2 (Calbiochem-
Novabiochem, Germany). 5 ml of the samples were analysed by
gelatin zymography.
Northern blot analysis
Total RNA was isolated from cells grown as monolayers or
within collagen gels using RNAzol™B according to the manu-
facturer’s instruction (WAK-Chemie, Germany). 10 mg of total
RNA were separated in 1% formaldehyde/agarose gels and
blotted onto nylon membranes (Amersham-Pharmacia-Biotech,
Germany). Filters were hybridized with 32P-labelled cDNA
probes for MT1-MMP (Sato et al, 1994), MMP-2 (Collier et al,
1988), and TIMP-2 (Stetler-Stevenson et al, 1990). As a control
for equal loading and the integrity of the RNA the filters were
rehybridized with a 32P-labelled 18S rRNA oligonucleotide
(Carlson et al, 1993).
Immunochemical analysis
For immunoblots crude plasma membrane preparations (20 mg)
were separated on 10% SDS polyacrylamide gels under reducing
conditions and transferred onto nitrocellulose membranes
(Amersham-Pharmacia-Biotech). After blockage with 5% non-
fat milk powder in PBS/0.5% (v/v) Tween the membranes were
incubated overnight with 1 mg ml–1 of the anti-MT1-MMP
peptide antibody 114–1F2 at 4°C, followed by an incubation
with a horseradish peroxidase conjugated anti-mouse IgG anti-
body (Dako, Germany) for 1 h. Bound antibodies were detected
with ECL according to the supplier’s protocol (Amersham-
Pharmacia-Biotech). For quantification of TIMP-2 protein levels
conditioned media combined with sonicated cells or collagen
gels (100 ml) were subjected to ELISA multiwell plates,
precoated with anti-TIMP-2 antibodies, and measured following
the supplier’s instructions (Amersham-Pharmacia-Biotech).
Serial dilutions of human recombinant TIMP-2 were used as
internal standards.Pro MMP-2 activation in epidermal tumour cells 1389
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RESULTS
Effect of cell–matrix interactions on proMMP-2
activation in non-tumorigenic HaCaT cells and in the
tumorigenic HaCaT clone II-4rt
HaCaT cells and the tumorigenic HaCaT cell clone II-4rt were
grown as monolayers on collagen type I coated dishes or within
three-dimensional fibrillar collagen lattices. On days 1, 3, 5 and 7
conditioned media were prepared and analysed by gelatin zymog-
raphy (Figure 1). In monolayer cultures both cells types produced
comparable amounts of MMP-2, but only in its latent form, while
MMP-9 production did clearly differ, being higher in II-4rt cells.
When cultured within a three-dimensional matrix composed of
native type I collagen fibrils, HaCaT cells continued to produce the
latent form of MMP-2, whereas the tumorigenic II-4rt cells gained
the capability to convert proMMP-2 into its 62/59 kDa active
forms. Surprisingly, the strong induction of proMMP-9 observed
in II-4rt monolayer cultures was greatly reduced by growing these
cells in contact with fibrillar collagen. Preincubation of II-4rt cells
with the MMP-inhibitor 1,10 phenanthroline and the synthetic
furin inhibitor CMK (Stieneke-Grober et al, 1992) resulted in
complete suppression of collagen type I-induced activation of
proMMP-2. The serine protease inhibitor aprotinin and the
specific urokinase inhibitors did not affect this activation process
(Figure 2). These observations indicate that MT-MMPs which
have been shown to be activated intracellularly by furin-like
protease are likely to be involved in proMMP-2 activation.
To test this, we prepared crude membrane fractions from HaCaT
and II-4rt cells cultivated as monolayers or within collagen gels
and incubated them with fibroblast conditioned medium con-
taining proMMP-2. Only the membrane fraction isolated from II-4rt
cells grown within the collagenous matrix showed activation of
fibroblast derived proMMP-2 (Figure 3).
MT1-MMP is constitutively expressed in HaCaT and
II-4rt cells under both culture conditions
In order to elucidate the mechanism underlying proMMP-2 activa-
tion in II-4rt cells, we analysed MMP-2 and MT1-MMP expression
on both transcript and protein levels. RNA analysis (Figure 4)
revealed low MMP-2 mRNA levels in HaCaT and II-4rt cells under
monolayer conditions. After contact with fibrillar collagen the
transcript levels increased significantly in both cell types.
Surprisingly, HaCaT cells as well as II-4rt cells displayed constitu-
tive expression of MT1-MMP mRNA in monolayer cultures with
higher levels found in II-4rt cells. In collagen gels both cell types
showed an induction of MT1-MMP mRNA to comparable levels.
As shown in Figure 5, membranes purified from HaCaT cells
grown as monolayers or within collagen gels for 24 h displayed
two immunoreactive bands of equal intensity, with the 63 kDa
band corresponding to proMT1-MMP and the 60 kDa band to the
active processed form of MT1-MMP (Lehti et al, 1998; Maquoi
et al, 1998). In contrast, membranes from II-4rt cells grown as
monolayers and within the collagenous matrix contained mainly
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Figure 1 Expression of type IV collagenases in non-tumorigenic HaCaT
cells and the c-rasHa-transfected HaCaT clone II-4rt. The two cell types were
cultivated either on collagen type I coated dishes (M) or within collagen
lattices (G). At days 1, 3, 5 and 7 the monolayer and collagen cultures were
washed with PBS and cultures continued for 24 h in serum-free medium.
Conditioned media corresponding to 1.5 ´ 104 cells were analysed by gelatin
zymography. Positions of proMMP-9, proMMP-2 and MMP-2 are indicated by
their molecular weights. The data presented here are representative of three
different experiments
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Figure 2 Inhibition of proMMP-2 activation by II-4rt cells grown in collagen
gels. Before seeding in collagen lattices, II-4rt cells were preincubated for
30 min at 37°C as follows: no inhibitor (lane 1), 1,10 phenanthroline (lane 2 =
10 mM, lane 3 = 20 mM), the furin inhibitor CMK (lane 4 = 25 mM, lane 5 =
50 mM), the CMK solvent methanol (lane 6), aprotinin (lane 7 = 20 mM) and
the uPA inhibitors UK1 (lane 8 = 20 mg ml–1) and ni68 (lane 9 = 20 mg ml–1).
After 24 h cultivation the collagen gels were washed with PBS and cultured in
serum-free medium containing fresh inhibitors. After 24 h the conditioned
media were combined with the collagen gels, homogenized and 10 ml of the
homogenates analysed by gelatin zymography
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Figure 3 Activation of exogenous proMMP-2 by crude membrane
preparations from HaCaT and II-4rt cells. Both cell types were grown as
monolayers or within collagen gels for 24 h. Then the cells were collected
and crude membranes prepared as described in Materials and Methods.
10 mg of the membrane preparations were incubated (24 h at 37°C) with 20 ml
fibroblast conditioned medium, containing proMMP-2. Activation of proMMP-
2 was assayed by gelatin zymography. As a control fibroblast conditioned
medium was applied in lane 1. The crude membrane preparations from
HaCaT (lane 2) and II-4rt (lane 4) monolayer cultures and from HaCaT (lane
3) and II-4rt (lane 5) collagen gel cultures are shown. The molecular sizes
(kDa) of the latent and active MMP-2 protein forms are marked to the right1390 P Baumann et al
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active MT1-MMP, while proMT1-MMP was barely detectable at
both time-points. Upon contact with fibrillar collagen, both cell
types showed an increase of the active form. Under this condition
the differences in the ratio of latent/active MT1-MMP in HaCaT
and II-4rt cells became even more obvious. The appearance of the
lower molecular weight protein band of about 45 kDa detected in
some membrane fractions is likely to be caused by further
processing of MT1-MMP, as described by Lehti et al (1998).
MT1-MMP and TIMP-2 play substantial roles for
proMMP-2 activation induced by fibrillar collagen in
II-4rt cells
To test whether MT1-MMP is involved in proMMP-2 activation
by II-4rt cells, membranes were isolated from II-4rt cells grown in
collagen gels for 24 h and incubated overnight with fibroblast
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Figure 4 Detection of MMP-2, MT1-MMP and TIMP-2 mRNA in the HaCaT
clones grown as monolayers (M) or within collagen gels (G). For RNA
extraction HaCaT cells (lanes 1 and 2) and II-4rt cells (lanes 3 and 4) were
cultivated for 24 h (lanes 1 and 3) or 72 h (lanes 2 and 4). 10 mg of the RNA
samples were separated in a 1% formaldhyde/agarose gel, blotted onto a
nylon membrane and hybridized successively with 32P-labelled cDNA probes
for MT1-MMP, TIMP-2 and MMP-2. RNA loading was assessed by
hybridization with an 18S rRNA oligonucleotide. Transcript lengths are 4.5 kb
for MT1-MMP, 3.0 kb for TIMP-2 and 3.1 kb for MMP-2
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Figure 5 Detection of latent and active MT1-MMP in crude membrane
preparations isolated from HaCaT and II-4rt cells. Membrane fractions (20 mg)
were separated on a 10% SDS/polyacrylamide gel under reducing
conditions. After transfer of the proteins onto a nitrocellulose membrane
MT1-MMP was detected with the monospecific peptide antibody 114-1F2
(1 mg ml–1) followed by incubation with a horseradish peroxidase conjugated
anti-mouse IgG antibody (1:2000). Bound antibodies were detected with the
ECL system. Membranes were isolated from HaCaT and II-4rt cells cultivated
for 1 or 3 days either as monolayers (M) or in collagen lattices (G). Molecular
weight standards (kDa) are indicated to the left
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Figure 6 Inhibition of membrane-mediated proMMP-2 activation by
MT1-MMP specific antibodies and by addition of recombinant TIMP-2. 10 mg
of crude membrane preparations from II-4rt cells grown in collagen gels for
24 h, were incubated with fibroblast conditioned medium (20 ml) containing
latent MMP-2 (lane 1). The incubations were performed either in the absence
(lane 2), or in the presence of 1 mg (lane 3), 5 mg (lane 4), and 10 mg (lane 5)
of MT1-MMP-specific antibodies, or in the presence of 5 ng (lane 6) and 10
ng (lane 7) recombinant TIMP-2, respectively. After incubation proMMP-2
activation was assayed by gelatin zymography
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Figure 7 TIMP-2 production by HaCaT cells and II-4rt cells cultivated as
monolayers or within collagen gels. HaCaT (black bars) and II-4rt (white bars)
cells were grown as monolayers and in collagen gels for 24 and 72 h. At
these time-points the cultures were washed with PBS and continued in
serum-free medium for a further 24 h. Then the cells/collagen gels were
combined with their conditioned media and homogenized. TIMP-2 levels
were determined using an ELISA as described in Materials and Methods.
Each bar represents the mean ± SEM of two independent experiments
performed in duplicate (P < 0.05)Pro MMP-2 activation in epidermal tumour cells 1391
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conditioned medium containing proMMP-2. Analysis by gelatin
zymography revealed activation of fibroblast derived proMMP-2
to the 62/59 kDa active forms (Figure 6, lane 2, see also Figure 3).
However, when the membranes were preincubated with increasing
amounts of MT1-MMP-specific antibodies, binding to the
catalytic center of MT1-MMP, proMMP-2 activation was
completely abolished in a concentration-dependent manner
(Figure 6, lanes 3–5) indicating that MT1-MMP is the membrane-
associated activator for proMMP-2 in II-4rt cells. The higher mole-
cular protein bands in this zymogram are presumably caused by
membrane aggregates containing MT1-MMP, MMP-2 and TIMP-
2. Incubation of the membrane fraction with the control antibody
anti-HLA-ABC did not result in inhibition of proMMP-2
activation (data not shown).
As both cell types showed active MT1-MMP on their cell
surface, although in different amounts, under both culture condi-
tions we asked whether different expression levels of TIMP-2 by
HaCaT and II-4rt cells might be critical for proMMP-2 activation.
Analysis of TIMP-2 mRNA expression did not reveal significant
differences between HaCaT and II-4rt cells grown in collagen
gels. (Figure 4). However, the amounts of TIMP-2 protein were
strikingly different (Figure 7). Upon contact with fibrillar
collagen, TIMP-2 production in II-4rt cells was found to be
strongly reduced when compared to monolayer culture, whereas
in HaCaT cultures the amount of TIMP-2 increased, resulting in
about 6-fold higher levels when compared to II-4rt cells. In
contrast, under monolayer conditions both cells types displayed
comparable high amounts of TIMP-2 protein. In addition,
proMMP-2 activation by membranes isolated from II-4rt cells
could be completely inhibited by addition of recombinant TIMP-
2 (Figure 6, lanes 6 and 7).
DISCUSSION
The proteolytic activity of MMP-2 and MMP-9, both degrading
type IV collagen in basement membranes, has been proposed to
play a critical role for tumour cell invasion which depends on the
destruction of tissue barriers.
In a recent study (Meade-Tollin et al, 1998) enhanced expres-
sion of these two MMPs was proposed to be associated with acqui-
sition of the tumorigenic phenotype of c-rasHa-transfected HaCaT
clones. In contrast to this report, we did not detect differences in
the amount of latent MMP-2 produced by the non-tumorigenic
HaCaT cells and the c-rasHa-transfected tumorigenic HaCaT
variant II-4rt under comparable culture conditions. However, for
MMP-9 the situation was markedly different, showing high
amounts of MMP-9 only in the malignant II-4rt cells. This is in
good agreement with reports demonstrating that MMP-9 induction
is mediated through the ras proto-oncogene (Gum et al, 1996).
Upon contact with fibrillar collagen the malignant II-4rt cells,
but not the non-tumorigenic HaCaT cells, showed activation of
proMMP-2 to its 62/59 kDa active forms. The membrane-
associated activation of proMMP-2 was completely abolished in
the presence of MT1-MMP-specific antibodies, clearly indicating
that other MT-MMPs, although low transcript levels were detected
by RT-PCR (data not shown), are not involved in the activation
process.
As are all other MMPs, MT1-MMP is synthesized as an inactive
zymogen. The mechanisms underlying proMT1-MMP activation
and the necessity for cleavage of the N-terminal peptide for its
activity are still controversially discussed. MT1-MMP can be
activated intracellularly by the protease furin (Pei and Weiss,
1996) and extracellularly by the serine proteases plasmin and
urokinase (Okumura et al, 1997; Kazes et al, 1998). However,
MT1-MMP-overexpressing COS cells have been shown to acti-
vate proMMP-2 without cleavage of proMT1-MMP by furin-like
proteases (Cao et al, 1996). In II-4rt cells conversion of latent
MMP-2 to the active 62/59 kDa form could be inhibited by the
furin inhibitor CMK (Stieneke-Grober et al, 1992), which prevents
intracellular activation of proMT1-MMP (Sato et al, 1996;
Kurschat et al, 1999). In contrast, the serine protease inhibitors had
no effect on the activation process. Furthermore, as we obtained
complete inhibition by the furin inhibitor our data convincingly
demonstrate that activation of proMT1-MMP by furin is a
prerequisite for proMMP-2 activation in II-4rt cells.
Conversion of latent MMP-2 to its active 62/59 kDa forms was
observed with II-4rt cells upon growth within collagen gels but not
on a collagenous substrate, indicating that activation of proMMP-
2 is highly dependent on interactions of the cells with the
surrounding matrix. Induction of proMMP-2 activation upon
contact with fibrillar collagen type I has also been described for
other cell types including fibroblasts (Azzam and Thompson,
1992; Seltzer et al, 1994; Gilles et al, 1997), microvascular
endothelial (Haas et al, 1998), and melanoma (Kurschat et al,
1999) cells. In contrast to fibroblasts and endothelial cells, which
showed a collagen-induced upregulation of MT1-MMP mRNA, in
melanoma cells MT1-MMP transcript levels were barely affected.
Instead, melanoma cells showed a collagen-dependent activation
of MT1-MMP which, however, did not correlate with the invasive
potential of the melanoma cell lines. In our cell system significant
amounts of active MT1-MMP protein were detected in all
membrane preparations, independent of the tumourigenic pheno-
type or culture conditions. However, proMMP-2 activation was
only obtained with membranes from II-4rt cells grown in collagen
gels. This observation strongly suggests that the presence of active
MT1-MMP is not sufficient to explain the activation differences
observed with HaCaT and II-4rt cells.
As pointed out by many reports, MT1-MMP-mediated activa-
tion of proMMP-2 is critically dependent on the amount of TIMP-
2 present in the system (Strongin et al, 1995; Will et al, 1996;
Butler et al, 1998; Itoh et al, 1998; Zucker et al, 1998). In mono-
layer cultures TIMP-2 levels were almost comparable in both cell
types. However, cultivation in fibrillar collagen induced a
dramatic reduction of TIMP-2 protein in II-4rt cells when
compared to HaCaT cells. Furthermore, proMMP-2 activation by
II-4rt membranes could be completely abolished by an excess of
recombinant TIMP-2. These findings indicate that TIMP-2 levels
might be critical for the activation process in epidermal cells.
Thereby the relative low TIMP-2 levels in II-4rt cells grown in
contact with the collagenous matrix might enable MT1-MMP-
mediated proMMP-2 activation, whereas the high levels in HaCaT
cells might be inhibitory for this process. Addition of recom-
binant TIMP-1, which has been shown to be a poor inhibitor of
proMMP-2 activation (Will et al, 1996), had no effect on
proMMP-2 activation (data not shown).
Our study indicates that activation of proMMP-2 rather than
enhanced expression might be associated with acquisition of the
tumourigenic phenotype in epidermal cells. However, differences
in the malignancy of cells might not become obvious unless such
more complex in vitro culture systems as three-dimensional
collagen lattices are used.ACKNOWLEDGEMENTS
We are grateful to Drs H Sato, N Fusenig and V Magdolen for
providing materials and to Dr B Eckes for critical reading of
the manuscript. This work was supported by Bundesminister-
ium für Bildung, Wissenschaft, Forschung und Technologie,
grants 01 GB 9703/6 and 01 KS 9502/10, and by Deutsche
Forschungsgemeinschaft, grant KR 558/10–1.
REFERENCES
Azzam HS and Thompson EW (1992) Collagen-induced activation of the Mr 72,000
type IV gelatinase in normal and malignant fibroblastoid cells. Cancer Res 52:
4540–4544
Birkedal-Hansen H, Moorie WGI, Bodden MK, Birkedal-Hansen B, DeCarlo A and
Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med
4: 197–250
Boukamp P, Petrusevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE
(1988) Normal keratinization in a spontaneously immortalized aneuploid
human keratinocyte cell line. J Cell Biol 106: 761–771
Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA and Fusenig NE (1990) c-Ha-ras
oncogene expression in immortalized human keratinocytes (HaCaT) alters
growth potential in vivo but lacks correlation with malignancy. Cancer Res 50:
2840–2847
Breitkreutz D, Schoop VM, Mirancea N, Baur M, Stark H-J and Fusenig NE (1998)
Epidermal differentiation and basement membrane formation by HaCaT cells
in surface transplants. Eur J Cell Biol 75: 273–286
Brown PD, Levy AT, Margulies IM, Liotta LA and Stetler-Stevenson WG (1990)
Independent expression and cellular processing of Mr 72,000 type IV
collagenase and interstitial collagenase in human tumorigenic cell lines.
Cancer Res 50: 6184–6191
Butler GS, Will H, Atkinson SJ and Murphy G (1997) Membrane-type-2 matrix
metalloproteinase can initiate the processing of progelatinase A and is
regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 244:
653–657
Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Schade van Westrum S,
Crabbe T, Clements J, d’Ortho MP and Murphy G (1998) The TIMP-2
membrane type metalloproteinase receptor regulates the concentration and
efficient activation of progelatinase A. J Biol Chem 273: 871–880
Cao J, Rehemtulla A, Bahou W and Zucker S (1996) Membrane-type matrix
metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the
N-terminal domain. J Biol Chem 271: 30174–30180
Carlson SG, Fawcett TW, Bartlett JD, Bernier M and Holbrook NJ (1993)
Regulation of the C/EBP related gene gadd153 by glucose deprivation. Mol
Cell Biol 13: 4736–4744
Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger,
He C, Bauer EA and Goldberg GI (1988) H-ras oncogene-transformed human
bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of
degrading basement membrane collagen. J Biol Chem 263: 6579–6587
Gilles C, Polette M, Seiki M, Birembaut P and Thompson EW (1997) Implication of
collagen type I-induced membrane-type 1 matrix metalloproteinase expression
and matrix metalloproteinase-2 activation in the metastatic progression of
breast carcinomas. Lab Invest 76: 651–660
Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M and Boyd D (1996):
Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-
activated protein kinase 1 independent and requires multiple transcription
factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J
Biol Chem 271: 10672–10680
Haas TI, Davis SJ and Madri JA (1998) Three-dimensional type I collagen lattices
induce coordinate expression of matrix metalloproteinase MT1-MMP and
MMP-2 in microvascular endothelial cells. J Biol Chem 273: 3604–3610
Herron GS, Benda MJ, Clark EJ, Gavrilovic J and Werb Z (1986) Secretion of
metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261:
2814–2818
Itoh Y, Ito A, Iwata K, Tanazawa K, Mori Y and Nagase H (1998) Plasma
membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically
inhibits matrix metalloproteinase 2 (gelatinase A) activation on the cell surface.
J Biol Chem 273: 24360–24367
Kazes I, Delarue F, Hagege J, Bouzhir-Sima L, Rondeau E, Sraer JD and Nguyen G
(1998) Soluble latent membrane-type 1 matrix metalloprotease secreted by
mesangial cells is activated by urokinase. Kidney Int 54: 1976–1984
Kurschat P, Zigrino P, Nischt R, Breitkopf K, Steurer P, Klein EC, Krieg T and
Mauch C (1999) Tissue inhibitor of matrix metalloproteinase-2 regulates
matrix metalloproteinase-2 activation by modulation of membrane-type 1
matrix metalloproteinase activity in high and low invasive melanoma cells.
J Biol Chem 274: 21056–21062
Kusukawa J, Sasaguri Y, Shima I, Kameyama T and Morimatsu M (1993)
Expression of matrix metalloproteinase-2 related to lymph node metastasis of
oral squamous cell carcinomas. A clinicopathologic study. Am J Clin Pathol
99: 18–23
Lehti K, Lohi J, Valtanen H and Keski-Oja J (1998) Proteolytic processing of
membrane-type 1 matrix metalloproteinase is associated with gelatinase A
activation at the cell surface. Biochem J 334: 345–353
Maquoi E, Noel A, Frankenne F, Angliker H, Murphy G and Foidart JM (1998)
Inhibition of matrix metalloproteinase-2 maturation and HT 1080 invasiveness
by a synthetic furin inhibitor. FEBS Lett 242: 262–266
Mauch C, Hatamochi A, Scharffetter K and Krieg T (1988) Regulation of collagen
synthesis in fibroblast within a three-dimensional collagen gel. Exp Cell Res
178: 493–503
Meade-Tollin LC, Boukamp P, Fusenig NE, Bowen CPR, Tsang TC and Bowden GT
(1998) Differential expression of matrix metalloproteinases in activated c-rasHa-
transfected immortalized human keratinocytes. Br J Cancer 77: 724–730
Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M,
Fujimoto N, Sato H, Seiki M and Okadea Y (1999) Enhanced production and
activation of progelatinase A mediated by membrane-type 1 matrix
metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59:
467–473
Okada A, Beloqc JP, Rouyer N, Chenard MP, Rio MC, Chambon P and Basset P
(1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed
in stromal cells of human colon, breast, head and neck carcinomas. Proc Natl
Acad Sci USA 92: 2730–2734
Okumura Y, Sato H, Seiki M and Kido H (1997) Proteolytic activation of the
precursor of membrane-type 1 matrix metalloproteinase by human plasmin.
FEBS Lett 402: 181–184
Pei D (1999) Identification and characterization of the fifth membrane-type matrix
metalloproteinase MT5-MMP. J Biol Chem 274: 8925–8933
Pei D and Weiss SJ (1996) Transmembrane-deletion mutants of the membrane-type
matrix metalloproteinase-1 process progelatinase A and express intrinsic
matrix-degrading activity. J Biol Chem 271: 9135–9140
Puente XS, Pendas AM, Ilano E, Velasco G and Lopez-Otin C (1996) Molecular
cloning of a novel membrane-type matrix metalloproteinase from a human
breast carcinoma. Cancer Res 56: 944–949
Pyke C, Ralfkiaer EH, Huhtala P, Hurskaninen T, Dano K and Tryggvason K (1992)
Localization of messenger RNA for Mr 72,000 and 92,000 type IV
collagenases in human skin cancers by in situ hybridization. Cancer Res 52:
1336–1241
Sato H, Takino T, Okada Y, Shinagawa A, Yamamoto E and Seiki M (1994) A
matrix metalloproteinase expressed on the surface of invasive tumor cells.
Nature 370: 61–65
Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler-Stevenson WG and Seiki M
(1996) Cell surface binding and activation of gelatinase A induced by
expression of membrane-type matrix metalloproteinase (MT1-MMP). FEBS
Lett 385: 238–240
Seltzer JL, Lee AY, Akers KT, Sudbeck B, Southon EA, Wayner EA and Eisen AZ
(1994) Activation of 72-kDa type IV collagenase/gelatinase by normal
fibroblasts in collagen lattices is mediated by integrin receptors but is not
related to lattice contraction. Exp Cell Res 213: 365–374
Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT and Liotta LA (1990) Tissue
inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell
lines and human tumor tissues. J Biol Chem 265: 13933–13938
Stetler-Stevenson WG, Aznavoorian S and Liotta LA (1993) Tumor cell interaction
with the extracellular matrix during invasion and metastasis. Annu Rev Cell
Biol 9: 541–573
Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD
and Garten W (1992) Influenza virus hemagglutinin with multibasic cleavage
site is activated by furin, a subtilisin-like endoprotease. EMBO J 11:
2407–2414
Strongin AY, Collier I, Banniko G, Marmer BL, Grant GA and Goldberg GI (1995)
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation
of the activated form of the membrane metalloprotease. J Biol Chem 270:
5331–5338
Takino T, Sato H, Shinagawa A and Seiki M (1995) Identification of the second
membrane-type matrix metalloproteinase (MT-MMP2) gene from a human
placenta cDNA library. MT-MMPs form a unique membrane-type subclass in
the MMP family. J Biol Chem 270: 23013–23020
1392 P Baumann et al
British Journal of Cancer (2000) 83(10), 1387–1393 © 2000 Cancer Research CampaignPro MMP-2 activation in epidermal tumour cells 1393
British Journal of Cancer (2000) 83(10), 1387–1393 © 2000 Cancer Research Campaign
Tomakidi P, Mirancea N, Fusenig NE, Herold-Mende C, Bosch FX and Breitkreutz
D (1999) Defects of basement membrane and hemidesmosome structure
correlate with malignant phenotype and stromal interactions in HaCaT-Ras
xenografts. Differentiation 64: 263–275
Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H and
Seiki M (1996) Expression of membrane-type matrix metalloproteinase-1
(MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental
metastasis assay. Cancer Res 56: 5678–5683
Will H and Hinzmann B (1995) cDNA sequence and mRNA distribution of a novel
human matrix metalloproteinase with a potential transmembrane domain. Eur J
Biochem 231: 602–608
Will H, Atkinson SJ, Butler GS, Smith B and Murphy G (1996) The soluble catalytic
domain of type 1 matrix metalloproteinase cleaves the propeptide of
progelatinase A and initiates autoproteolytic activation. J Biol Chem 271:
17119–17123
Yu AE, Hewitt RE, Kleiner DE and Stetler-Stevenson WG (1997) Molecular
regulation of cellular invasion – role of gelatinase A and TIMP-2. Biochem Cell
Biol 74: 823–831
Zucker S, Drews M, Conner C, Foda HD, DeClerk YA, Langley KE, Bahou WF,
Docherty AJP and Cao J (1998) Tissue inhibitor of metalloproteinase-
(TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane
type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216–1222